Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 407-416

  Aleskandarany, Mohammed A ^a,b   Rakha, Emad A ^c   Ahmed, Mohamed A ^a,d   Powe, Desmond G ^c   Ellis, Ian O ^a,c   Green, Andrew R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MENOUFIA UNIVERSITY   (Egypt)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Breast cancer; Immunohistochemistry; Oncogene; pAkt PKB

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; ESTROGEN RECEPTOR; KI 67 ANTIGEN; P CADHERIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SERINE; UVOMORULIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MENOPAUSE; OUTCOME ASSESSMENT; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME; WESTERN BLOTTING;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79958189562     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1012-y     Document Type: Article

References (42)

1. YR Chin A Toker 2009 Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer Cell Signal 21 470 476 19110052 10.1016/j.cellsig.2008.11.015 1:CAS:528:DC%2BD1MXhvF2rtbk%3D
2. G Song G Ouyang S Bao 2005 The activation of Akt/PKB signaling pathway and cell survival J Cell Mol Med 9 59 71 15784165 10.1111/j.1582-4934.2005. tb00337.x 1:CAS:528:DC%2BD2MXlt1eqtLo%3D
3. A Arcaro AS Guerreiro 2007 The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications Curr Genomics 8 271 306 19384426 10.2174/138920207782446160 1:CAS:528:DC%2BD1cXhsVGmsQ%3D%3D (Pubitemid 351210980)
4. DA Altomare JR Testa 2005 Perturbations of the AKT signaling pathway in human cancer Oncogene 24 7455 7464 16288292 10.1038/sj.onc.1209085 1:CAS:528:DC%2BD2MXht1Wis7vO (Pubitemid 41637985)
5. JA Engelman 2009 Targeting PI3K signalling in cancer: opportunities, challenges and limitations Nat Rev Cancer 9 550 562 19629070 10.1038/nrc2664 1:CAS:528:DC%2BD1MXovFylsrg%3D
6. BH Jiang LZ Liu 2009 PI3K/PTEN signaling in angiogenesis and tumorigenesis Adv Cancer Res 102 19 65 19595306 10.1016/S0065-230X(09)02002-8 1:CAS:528:DC%2BD1MXht1ektLbM
7. BH Jiang LZ Liu 2008 PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim Biophys Acta 1784 150 158 17964232 1:CAS:528: DC%2BD1cXptlertQ%3D%3D
8. PK Vogt M Aoki I Bottoli HW Chang S Fu A Hecht JS Iacovoni BH Jiang U Kruse 1999 A random walk in oncogene space: the quest for targets Cell Growth Differ 10 777 784 10616902 1:CAS:528:DC%2BD3cXhslagsg%3D%3D (Pubitemid 30036249)
9. JR Woodgett 2005 Recent advances in the protein kinase B signaling pathway Curr Opin Cell Biol 17 150 157 15780591 10.1016/j.ceb.2005.02.010 1:CAS:528:DC%2BD2MXisVCqtb8%3D (Pubitemid 40380938)
10. RW Matheny Jr ML Adamo 2009 Current perspectives on Akt Akt-ivation and Akt-ions Exp Biol Med (Maywood) 234 1264 1270 10.3181/0904-MR-138 1:CAS:528:DC%2BD1MXhtlOitrfP
11. DD Sarbassov DA Guertin SM Ali DM Sabatini 2005 Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex Science 307 1098 1101 15718470 10.1126/science.1106148 1:CAS:528:DC%2BD2MXhtlSrtbY%3D (Pubitemid 40262113)
12. J Paez WR Sellers 2003 PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling Cancer Treat Res 115 145 167 12613196 10.1007/0-306-48158-8- 6 1:CAS:528:DC%2BD3sXnt12gs7k%3D
13. B-H Jiang L-Z Liu 2008 PI3K/PTEN signaling in tumorigenesis and angiogenesis Biochim Biophys Acta: Proteins Proteomics 1784 150 158 10.1016/j.bbapap.2007.09.008 1:CAS:528:DC%2BD1cXptlertQ%3D%3D
14. SP Staal 1987 Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma Proc Natl Acad Sci USA 84 5034 5037 3037531 10.1073/pnas.84.14. 5034 1:CAS:528:DyaL2sXkvFWhtb8%3D (Pubitemid 17095859)
15. JD Carpten AL Faber C Horn GP Donoho SL Briggs CM Robbins G Hostetter S Boguslawski TY Moses S Savage M Uhlik A Lin J Du YW Qian DJ Zeckner G Tucker-Kellogg J Touchman K Patel S Mousses M Bittner R Schevitz MH Lai KL Blanchard JE Thomas 2007 A transforming mutation in the pleckstrin homology domain of AKT1 in cancer Nature 448 439 444 17611497 10.1038/nature05933 1:CAS:528:DC%2BD2sXotFajtbk%3D (Pubitemid 47123510)
16. TL Yuan LC Cantley 2008 PI3K pathway alterations in cancer: variations on a theme Oncogene 27 5497 5510 18794884 10.1038/onc.2008.245 1:CAS:528:DC%2BD1cXhtFWiurzI
17. YO Al-Bazz BL Brown JC Underwood RL Stewart PR Dobson 2009 Immuno-analysis of phospho-Akt in primary human breast cancers Int J Oncol 35 1159 1167 19787271 1:CAS:528:DC%2BD1MXhtlCgur3M
18. C Blanco-Aparicio O Renner JFM Leal A Carnero 2007 PTEN, more than the AKT pathway Carcinogenesis 28 1379 1386 17341655 10.1093/carcin/bgm052 1:CAS:528:DC%2BD2sXos12ju78%3D (Pubitemid 47243536)
19. V Shtilbans M Wu DE Burstein 2008 Current overview of the role of Akt in cancer studies via applied immunohistochemistry Ann Diagn Pathol 12 153 160 18325479 10.1016/j.anndiagpath.2007.12.001 (Pubitemid 351312912)
20. Y Wu H Mohamed R Chillar I Ali S Clayton D Slamon JV Vadgama 2008 Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer Breast Cancer Res 10 R3 18184439 10.1186/bcr1844
21. T Frogne AV Laenkholm MB Lyng KL Henriksen AE Lykkesfeldt 2009 Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors Breast Cancer Res 11 R11 19239686 10.1186/bcr2230
22. KM Vasudevan DA Barbie MA Davies R Rabinovsky CJ McNear JJ Kim BT Hennessy H Tseng P Pochanard SY Kim IF Dunn AC Schinzel P Sandy S Hoersch Q Sheng PB Gupta JS Boehm JH Reiling S Silver Y Lu K Stemke-Hale B Dutta C Joy AA Sahin AM Gonzalez-Angulo A Lluch LE Rameh T Jacks DE Root ES Lander GB Mills WC Hahn WR Sellers LA Garraway 2009 AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer Cancer Cell 16 21 32 19573809 10.1016/j.ccr.2009.04.012 1:CAS:528:DC%2BD1MXhtVWnsL7M
23. K Stemke-Hale AM Gonzalez-Angulo A Lluch RM Neve WL Kuo M Davies M Carey Z Hu Y Guan A Sahin WF Symmans L Pusztai LK Nolden H Horlings K Berns MC Hung MJ van de Vijver V Valero JW Gray R Bernards GB Mills BT Hennessy 2008 An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer Cancer Res 68 6084 6091 18676830 10.1158/0008-5472.CAN-07-6854 1:CAS:528:DC%2BD1cXpt1SqtLs%3D
24. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2005 REporting recommendations for tumor MARKer prognostic studies (REMARK) Nat Clin Pract Oncol 2 416 422 16130938 10.1038/ncponc0252 1:CAS:528:DC%2BD2MXps1CksLY%3D (Pubitemid 43115010)
25. DM Abd El-Rehim G Ball SE Pinder E Rakha C Paish JFR Robertson D Macmillan RW Blamey IO Ellis 2005 High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses Int J Cancer 116 340 350 15818618 10.1002/ijc.21004 1:CAS:528:DC%2BD2MXmtl2ktb0%3D (Pubitemid 40993329)
26. EA Rakha SE Elsheikh MA Aleskandarany HO Habashi AR Green DG Powe ME El-Sayed A Benhasouna JS Brunet LA Akslen AJ Evans R Blamey JS Reis-Filho WD Foulkes IO Ellis 2009 Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes Clin Cancer Res 15 2302 2310 19318481 10.1158/1078-0432.CCR-08-2132 1:CAS:528:DC%2BD1MXjvVWltbs%3D
27. A Albasri R Seth D Jackson A Benhasouna S Crook AS Nateri R Chapman M Ilyas 2009 C-terminal tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer J Pathol 218 57 65 19214987 10.1002/path.2508 1:CAS:528:DC%2BD1MXls1Ort70%3D
28. KS McCarty Jr LS Miller EB Cox J Konrath KS McCarty Sr 1985 Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies Arch Pathol Lab Med 109 716 721 3893381 (Pubitemid 16237466)
29. S Bose S Chandran JM Mirocha N Bose 2006 The Akt pathway in human breast cancer: a tissue-array-based analysis Mod Pathol 19 238 245 16341149 10.1038/modpathol.3800525 1:CAS:528:DC%2BD28Xlt1eqsA%3D%3D (Pubitemid 43117608)
30. AR Panigrahi SE Pinder SY Chan EC Paish JF Robertson IO Ellis 2004 The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome J Pathol 204 93 100 15307142 10.1002/path.1611 1:CAS:528:DC%2BD2cXot1alsb0%3D (Pubitemid 39214486)
31. ES Gershtein AM Scherbakov VA Shatskaya NE Kushlinsky MA Krasil'nikov 2007 Phosphatidylinositol 3-kinase/AKT signalling pathway components in human breast cancer: clinicopathological correlations Anticancer Res 27 1777 1782 17649772 1:CAS:528:DC%2BD2sXotVCrur4%3D (Pubitemid 46954675)
32. AM Florena C Tripodo C Guarnotta S Ingrao R Porcasi A Martorana G Lo Bosco D Cabibi V Franco 2007 Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients Pathobiology 74 317 322 18087195 10.1159/000110024 1:CAS:528:DC%2BD2sXhsVentLvL (Pubitemid 350273702)
33. YO Al-Bazz JCE Underwood BL Brown PRM Dobson 2009 Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer Eur J Cancer 45 694 704 19138840 10.1016/j.ejca.2008.11.044 1:CAS:528:DC%2BD1MXitF2gtLo%3D
34. MA Aleskandarany AR Green EA Rakha RA Mohammed SE Elsheikh DG Powe EC Paish RD Macmillan S Chan SI Ahmed IO Ellis 2010 Growth fraction as a predictor of response to chemotherapy in node negative breast cancer J Cancer 126 7 1761 1769 1:CAS:528:DC%2BC3cXhtl2it70%3D
35. A Basu 2008 Molecular targets of breast cancer: AKTing in concert Breast Cancer 2 11 16 19430575 1:CAS:528:DC%2BD1cXpvV2htb8%3D
36. A Zaczek B Brandt KP Bielawski 2005 The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches Histol Histopathol 20 1005 1015 15944951 1:CAS:528:DC%2BD2MXpsFKjtL0%3D (Pubitemid 40932618)
37. W Shi X Zhang M Pintilie N Ma N Miller D Banerjee MS Tsao T Mak A Fyles FF Liu 2003 Dysregulated PTEN-PKB and negative receptor status in human breast cancer Int J Cancer 104 195 203 12569575 10.1002/ijc.10909 1:CAS:528: DC%2BD3sXhvFykt7s%3D (Pubitemid 36249795)
38. HK Lin S Yeh HY Kang C Chang 2001 Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor Proc Natl Acad Sci USA 98 7200 7205 11404460 10.1073/pnas.121173298 1:CAS:528:DC%2BD3MXkslWmt7k%3D (Pubitemid 32567926)
39. CL Brooks W Gu 2006 p53 ubiquitination: Mdm2 and beyond Mol Cell 21 307 315 16455486 10.1016/j.molcel.2006.01.020 1:CAS:528:DC%2BD28Xhslehurk%3D (Pubitemid 43163526)
40. E Tokunaga A Kataoka Y Kimura E Oki K Mashino K Nishida T Koga M Morita Y Kakeji H Baba S Ohno Y Maehara 2006 The association between Akt activation and resistance to hormone therapy in metastatic breast cancer Eur J Cancer 42 629 635 16464571 10.1016/j.ejca.2005.11.025 1:CAS:528:DC%2BD28Xit1Citbc%3D (Pubitemid 43343685)
41. K Collett F Hartveit R Skjaerven BO Maehle 1996 Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status J Clin Pathol 49 920 925 8944613 10.1136/jcp.49.11. 920 1:STN:280:DyaK2s7gtVSntA%3D%3D (Pubitemid 26403163)
42. TA Yap MD Garrett MI Walton F Raynaud JS de Bono P Workman 2008 Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises Curr Opin Pharmacol 8 393 412 18721898 10.1016/j.coph.2008.08.004 1:CAS:528:DC%2BD1cXhtFCktL7E